Have a feature idea you'd love to see implemented?
Let us know!
NKTX Nkarta Inc
Price (delayed)
$3.485
Market cap
$245.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.01
Enterprise value
$208.33M
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with
Highlights
NKTX's EPS is up by 21% year-on-year and by 14% since the previous quarter
Nkarta's net income has increased by 14% YoY and by 7% QoQ
NKTX's quick ratio is up by 47% year-on-year but it is down by 21% since the previous quarter
Nkarta's equity has increased by 43% YoY but it has decreased by 4.3% QoQ
Key stats
What are the main financial stats of NKTX
Market
Valuations
Earnings
Shares outstanding
70.56M
Market cap
$245.9M
Enterprise value
$208.33M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.54
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$107.91M
EBITDA
-$96.88M
Free cash flow
-$109.55M
Per share
Balance sheet
Liquidity
EPS
-$2.01
Free cash flow per share
-$1.49
Book value per share
$6.43
Revenue per share
$0
TBVPS
$7.54
Total assets
$554.09M
Total liabilities
$100.9M
Debt
$85.57M
Equity
$453.18M
Working capital
$310.94M
Debt to equity
0.19
Current ratio
15.91
Quick ratio
15.7
Net debt/EBITDA
0.39
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-22.5%
Return on equity
-28.8%
Return on invested capital
-25%
Return on capital employed
-20.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NKTX stock price
How has the Nkarta stock price performed over time
Intraday
2.2%
1 week
-9.95%
1 month
-22.9%
1 year
71.67%
YTD
-47.2%
QTD
-22.9%
Financial performance
How have Nkarta's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$123.96M
Net income
-$107.91M
Gross margin
N/A
Net margin
N/A
Nkarta's net income has increased by 14% YoY and by 7% QoQ
Nkarta's operating income has increased by 9% YoY and by 4.7% from the previous quarter
Growth
What is Nkarta's growth rate over time
Valuation
What is Nkarta stock price valuation
P/E
N/A
P/B
0.54
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
NKTX's EPS is up by 21% year-on-year and by 14% since the previous quarter
The P/B is 74% below the 5-year quarterly average of 2.0 and 41% below the last 4 quarters average of 0.9
Nkarta's equity has increased by 43% YoY but it has decreased by 4.3% QoQ
Efficiency
How efficient is Nkarta business performance
NKTX's return on equity is up by 17% year-on-year and by 16% since the previous quarter
The ROA has grown by 16% YoY and by 13% from the previous quarter
NKTX's return on invested capital is up by 9% since the previous quarter and by 3.1% year-on-year
Dividends
What is NKTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NKTX.
Financial health
How did Nkarta financials performed over time
The current ratio has grown by 48% YoY but it has contracted by 20% from the previous quarter
NKTX's quick ratio is up by 47% year-on-year but it is down by 21% since the previous quarter
NKTX's debt is 81% smaller than its equity
Nkarta's equity has increased by 43% YoY but it has decreased by 4.3% QoQ
NKTX's debt to equity is down by 32% year-on-year but it is up by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.